UBS Reiterates Neutral Rating on Clorox (CLX) Amid Lack of Visibility Into Earnings, Revenue
Tweet Send to a Friend
UBS analyst Peter Grom reiterated a Neutral rating and $110.00 price target on Clorox (NYSE: CLX).The analyst commented, "CLX is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
